MedMira Historical Financial Ratios
MIR Stock | CAD 0.08 0.00 0.00% |
MedMira is lately reporting on over 86 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Average Payables of 1.8 M will help investors to properly organize and evaluate MedMira financial condition quickly.
MedMira |
About MedMira Financial Ratios Analysis
MedMiraFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate MedMira investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on MedMira financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across MedMira history.
MedMira Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing MedMira stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on MedMira sales, a figure that is much harder to manipulate than other MedMira multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Average Inventory
The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from MedMira's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into MedMira current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MedMira. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, MedMira's Price To Sales Ratio is fairly stable compared to the past year. Days Sales Outstanding is likely to climb to 1,237 in 2024, whereas Book Value Per Share is likely to drop (0.02) in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.24 | 0.27 | 0.0685 | 0.0651 | Days Of Inventory On Hand | 113.74 | 76.76 | 349.22 | 331.76 |
MedMira fundamentals Correlations
Click cells to compare fundamentals
MedMira Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MedMira fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Price To Sales Ratio | 300.86 | 36.84 | 92.93 | 145.12 | 166.89 | 175.24 | |
Ptb Ratio | (17.77) | (5.02) | (7.16) | (4.18) | (3.76) | (3.95) | |
Days Sales Outstanding | 82.53 | 212.87 | 524.83 | 1.2K | 1.2K | 1.2K | |
Book Value Per Share | (0.0236) | (0.0239) | (0.0182) | (0.0216) | (0.0194) | (0.0204) | |
Free Cash Flow Yield | (0.001511) | (0.006851) | (0.0221) | (0.0202) | (0.0182) | (0.0191) | |
Operating Cash Flow Per Share | (4.8E-4) | (7.67E-4) | (0.002768) | (0.001818) | (0.001636) | (0.001718) | |
Average Payables | 2.0M | 2.5M | 2.7M | 3.0M | 2.7M | 1.8M | |
Pb Ratio | (17.77) | (5.02) | (7.16) | (4.18) | (3.76) | (3.95) | |
Ev To Sales | 313.38 | 43.29 | 101.61 | 166.53 | 18.09 | 17.18 | |
Free Cash Flow Per Share | (6.35E-4) | (8.22E-4) | (0.00287) | (0.00182) | (0.001638) | (0.001719) | |
Roic | 0.21 | 0.0352 | 0.26 | 0.25 | 0.23 | 0.22 | |
Inventory Turnover | 1.56 | 1.79 | 3.21 | 4.76 | 1.05 | 1.92 | |
Net Income Per Share | (0.003107) | (0.001027) | (0.002691) | (0.003836) | (0.003453) | (0.003625) | |
Days Of Inventory On Hand | 234.27 | 203.58 | 113.74 | 76.76 | 349.22 | 331.76 | |
Payables Turnover | 0.15 | 0.16 | 0.24 | 0.27 | 0.0685 | 0.0651 | |
Sales General And Administrative To Revenue | 1.27 | 0.23 | 0.77 | 1.95 | 2.9 | 2.18 | |
Research And Ddevelopement To Revenue | 0.22 | 0.17 | 0.2 | 1.09 | 1.16 | 1.49 | |
Cash Per Share | 6.1E-4 | (0.003499) | 4.9E-5 | 1.9E-5 | 1.7E-5 | 1.8E-5 | |
Pocfratio | (875.33) | (156.55) | (46.97) | (49.51) | (56.94) | (59.79) | |
Interest Coverage | (1.79) | (0.28) | (2.63) | (2.2) | (2.92) | (3.06) | |
Pfcf Ratio | (661.87) | (145.97) | (45.29) | (49.46) | (56.88) | (59.73) | |
Days Payables Outstanding | 2.4K | 2.3K | 1.5K | 1.4K | 5.3K | 5.6K | |
Income Quality | 0.15 | 0.75 | 1.03 | 0.47 | 0.88 | 0.72 | |
Roe | 0.22 | 0.16 | 0.13 | 0.043 | 0.15 | 0.18 | |
Ev To Operating Cash Flow | (911.76) | (183.97) | (51.35) | (56.82) | (2.54) | (2.67) | |
Pe Ratio | (135.19) | (116.9) | (48.31) | (23.46) | (26.98) | (28.33) | |
Return On Tangible Assets | (0.6) | (0.17) | (0.48) | (0.73) | (0.55) | (0.58) | |
Ev To Free Cash Flow | (689.41) | (171.55) | (49.52) | (56.76) | (2.03) | (2.13) | |
Net Debt To E B I T D A | (10.22) | 74.69 | (7.74) | (5.87) | (3.5) | (3.32) | |
Current Ratio | 0.0178 | 0.0576 | 0.0905 | 0.12 | 0.11 | 0.18 | |
Tangible Book Value Per Share | (0.0236) | (0.0239) | (0.0182) | (0.0216) | (0.0194) | (0.0204) | |
Receivables Turnover | 4.42 | 1.71 | 0.7 | 0.3 | 0.31 | 0.29 | |
Graham Number | 0.0406 | 0.0235 | 0.0332 | 0.0431 | 0.0496 | 0.0471 | |
Shareholders Equity Per Share | (0.0236) | (0.0239) | (0.0182) | (0.0216) | (0.0194) | (0.0204) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MedMira Stock Analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.